Literature DB >> 1931832

Genetic and physical mapping of the human cannabinoid receptor gene to chromosome 6q14-q15.

M R Hoehe1, L Caenazzo, M M Martinez, W T Hsieh, W S Modi, E S Gershon, T I Bonner.   

Abstract

A cDNA encoding a G protein-coupled receptor that appears to mediate the behavioral effects of cannabinoids, the psychoactive ingredients of marijuana, has recently been cloned from rat cerebral cortex and expressed. We have now determined the genomic location of the human cannabinoid receptor gene (CNR) by a combination of genetic linkage mapping and chromosomal in situ hybridization. The segregation pattern of a CNR DNA polymorphism was analyzed in 508 individuals from two or three generations of 40 families. Linkage of CNR to chromosome 6 centromeric loci and to DNA markers on the long and short arms was detected. CNR was tightly linked to D6S27, which is known to be located at 6q (log10 odds ratio [lod score, Zmax] of 10.54 at a recombination fraction [theta] of 0.02). Close linkage was suggested between CNR and CGA, the locus for the alpha subunit of human chorionic gonadotropin (Zmax = 2.71 at theta = 0). Moreover, CNR was linked to the two markers 308/BamHI (theta = 0.14) and 308/TaqI (theta = 0.20) defining locus D6Z1, an extended, highly repetitive, and highly conserved sequence localized exclusively to centromeres of all chromosomes and enriched on chromosome 6. In situ hybridization using a biotinylated cosmid probe localizes the gene to 6q14-q15, thereby confirming the linkage analysis and defining a precise alignment of the genetic and cytogenetic maps.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1931832

Source DB:  PubMed          Journal:  New Biol        ISSN: 1043-4674


  24 in total

Review 1.  Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches.

Authors:  Peter J Goadsby
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Association study of the CNR1 gene exon 3 alternative promoter region polymorphisms and substance dependence.

Authors:  Aryeh I Herman; Henry R Kranzler; Joseph F Cubells; Joel Gelernter; Jonathan Covault
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-07-05       Impact factor: 3.568

3.  The gene encoding the central cannabinoid receptor is located in proximal mouse Chromosome 4.

Authors:  L Stubbs; L Chittenden; A Chakrabarti; E Onaivi
Journal:  Mamm Genome       Date:  1996-02       Impact factor: 2.957

Review 4.  Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.

Authors:  Antonia Serrano; Loren H Parsons
Journal:  Pharmacol Ther       Date:  2011-07-18       Impact factor: 12.310

5.  Physical and genetic localization of the bovine cannabinoid receptor (CNR1) gene to bovine chromosome 9.

Authors:  M Pfister-Genskow; G D Weesner; H Hayes; A Eggen; M D Bishop
Journal:  Mamm Genome       Date:  1997-04       Impact factor: 2.957

6.  Developmentally Specific Associations Between CNR1 Genotype and Cannabis Use Across Emerging Adulthood.

Authors:  James R Ashenhurst; K Paige Harden; Travis T Mallard; William R Corbin; Kim Fromme
Journal:  J Stud Alcohol Drugs       Date:  2017-09       Impact factor: 2.582

Review 7.  Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?

Authors:  Nadia Solowij; Patricia T Michie
Journal:  J Psychiatry Neurosci       Date:  2007-01       Impact factor: 6.186

8.  Association of polymorphisms of the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes with heroin addiction: impact of long repeats of CNR1.

Authors:  D Proudnikov; T Kroslak; J C Sipe; M Randesi; D Li; S Hamon; A Ho; J Ott; M J Kreek
Journal:  Pharmacogenomics J       Date:  2009-12-15       Impact factor: 3.550

9.  The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease.

Authors:  Martin Storr; Dominik Emmerdinger; Julia Diegelmann; Simone Pfennig; Thomas Ochsenkühn; Burkhard Göke; Peter Lohse; Stephan Brand
Journal:  PLoS One       Date:  2010-02-26       Impact factor: 3.240

10.  Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors.

Authors:  S Akerman; H Kaube; P J Goadsby
Journal:  Br J Pharmacol       Date:  2004-07-26       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.